Reference data : LOINC code

Filter

Filter on:	In :	Clear filter

Filter on:	In :

Filter on:	In :

Results

Loinc Number	Component	Property	System	Time aspect	ScaleType	MethodType	loincStatus	Long Common name	chngType	<span class='defaultText'>DefinitionDescription</span>	exampleUnits	exmplAnswers	loincClass	loincNum	methodTyp	orderObs	shortName	unitsRequired	relatedNames2	VersionLastChanged	VersionFirstRelease	EXTERNAL_COPYRIGHT_LINK	HL7_ATTACHMENT_STRUCTURE	CONSUMER_NAME	EXAMPLE_UCUM_UNITS	STATUS_REASON	STATUS_TEXT	CHANGE_REASON_PUBLIC	COMMON_TEST_RANK	COMMON_ORDER_RANK
35362-3	Triglyceride.in chylomicrons	PrThr	Ser/Plas	Pt	Ord		ACTIVE	Triglyceride in Chylomicrons [Presence] in Serum or Plasma	MIN	DefinitionDescription		Detected;Not detected	CHEM	35362-3		Both	Trig in Chylo SerPl Ql	N	Cardio; Cardiology; Chemistry; Chylomicron; Heart Disease; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tg; Trig; Trig in Chylo; Trigly; Triglycerides; Triglycrides; ULDL; Ultra low density lipoproteins	2.56	2.13								The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35363-1	Triglyceride.in chylomicrons	MCnc	Ser/Plas	Pt	Qn		ACTIVE	Triglyceride in Chylomicrons [Mass/volume] in Serum or Plasma	MIN	DefinitionDescription	mg/dL		CHEM	35363-1		Both	Trig in Chylo SerPl-mCnc	N	Cardio; Cardiology; Chemistry; Chylomicron; Heart Disease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tg; Trig; Trig in Chylo; Trigly; Triglycerides; Triglycrides; ULDL; Ultra low density lipoproteins	2.73	2.13					mg/dL				0
35364-9	Triacylglycerol lipase^1st specimen post dose sincalide	CCnc	Body fld	Pt	Qn		ACTIVE	Lipase [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide	MIN	DefinitionDescription	arb U/L		CHAL	35364-9		Observation	Lipase sp1 p sincalide Fld-cCnc	N	Acute specimen; After; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; First; Fl; Fld; FLU; Fluid; Kinevac; LIPA; Lipase; LPS; p dose; Pancreatic lipase; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; sp1; sp1 p sincalide; Spec; Steapsin; Tributyrase; Tributyrinase	2.68	2.13					U/L				0
35365-6	Vitamin D+Metabolites	MCnc	Ser/Plas	Pt	Qn		ACTIVE	Vitamin D+Metabolites [Mass/volume] in Serum or Plasma	MIN	DefinitionDescription	ng/mL		CHEM	35365-6		Both	Vit D+metab SerPl-mCnc	N	Chemistry; Dextro; Level; Mass concentration; Metabolite; Metb; Osteoporosis; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rickets; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total Vitamin D; UniversalLabOrders; Vit D+metab; Vitamin D deficiency	2.73	2.13					ng/mL				0
35366-4	SCA2 gene allele 2.CAG repeats	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	SCA2 gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.NUCREPEAT	35366-4	Molgen	Observation	SCA2 allele2 CAG Rpt Bld/T Ql	N	ASL13; Ataxia-2; Ataxin 2; ATX2; ATXN2; Blood; Genetics; Heredity; Heritable; II; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.NUCREPEAT; Olivopontocerebellar ataxia 2; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Repeat; SCA; SCA2; SCA2 allele2 CAG Rpt; Screen; Spinocerebellar ataxia; Tissue; Tissue, unspecified; TNRC13; WB; Whole blood; Whole blood or Tissue	2.56	2.13								Changed Property from Arb (Arbitrary) to 'Threshold' since the results (e.g. positive, intermediate, negative) is based on the number of nucleotide repeats. Moved term from Class MOLPATH.TRINUC to MOLPATH.NUCREPEAT, a Class used to group together observations for nucleotide repeats.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35367-2	SCA2 gene allele 1.CAG repeats	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	SCA2 gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.NUCREPEAT	35367-2	Molgen	Observation	SCA2 allele1 CAG Rpt Bld/T Ql	N	ASL13; Ataxia-2; Ataxin 2; ATX2; ATXN2; Blood; Genetics; Heredity; Heritable; i; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.NUCREPEAT; Olivopontocerebellar ataxia 2; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Repeat; SCA; SCA2; SCA2 allele1 CAG Rpt; Screen; Spinocerebellar ataxia; Tissue; Tissue, unspecified; TNRC13; WB; Whole blood; Whole blood or Tissue	2.56	2.13								Changed Property from Arb (Arbitrary) to 'Threshold' since the results (e.g. positive, intermediate, negative) is based on the number of nucleotide repeats. Moved term from Class MOLPATH.TRINUC to MOLPATH.NUCREPEAT, a Class used to group together observations for nucleotide repeats.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35368-0	SCA1 gene allele 2.CAG repeats	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	SCA1 gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.NUCREPEAT	35368-0	Molgen	Observation	SCA1 allele2 CAG Rpt Bld/T Ql	N	Ataxia-1; Ataxin 1; ATX1; ATXN1; Blood; caspase 3, apoptosis-related cysteine peptidase; CPP32; CPP32B; D6S504E; Genetics; Heredity; Heritable; II; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.NUCREPEAT; Olivopontocerebellar ataxia 1; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Repeat; SCA; SCA-1; SCA1 allele2 CAG Rpt; Screen; Spinocerebellar ataxia; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.56	2.13								Changed Property from Arb (Arbitrary) to 'Threshold' since the results (e.g. positive, intermediate, negative) is based on the number of nucleotide repeats. Moved term from Class MOLPATH.TRINUC to MOLPATH.NUCREPEAT, a Class used to group together observations for nucleotide repeats.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35369-8	SCA1 gene allele 1.CAG repeats	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	SCA1 gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.NUCREPEAT	35369-8	Molgen	Observation	SCA1 allele1 CAG Rpt Bld/T Ql	N	Ataxia-1; Ataxin 1; ATX1; ATXN1; Blood; caspase 3, apoptosis-related cysteine peptidase; CPP32; CPP32B; D6S504E; Genetics; Heredity; Heritable; i; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.NUCREPEAT; Olivopontocerebellar ataxia 1; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Repeat; SCA; SCA-1; SCA1 allele1 CAG Rpt; Screen; Spinocerebellar ataxia; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.56	2.13								The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
3537-8	Nordiazepam	MCnc	Ser/Plas	Pt	Qn		ACTIVE	Nordiazepam [Mass/volume] in Serum or Plasma	MIN	DefinitionDescription	mcg/dL; mcg/mL; ng/mL		DRUG/TOX	3537-8		Both	Nordiazepam SerPl-mCnc	Y	Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Pl; Plasma; Plsm; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stilny; Tranxilium N; Vegesan	2.73	1					ng/mL				0
35370-6	GBA gene.g.S84GG	Arb	Bld/Tiss	Pt	Ord	Molgen	DEPRECATED	Deprecated GBA gene.g.S84GG [Presence] in Blood or Tissue by Molecular genetics method	DEL	DefinitionDescription			MOLPATH.MUT	35370-6	Molgen	Both	Deprecated GBA g.S84GG Bld/T Ql	N	Arbitrary; Beta glucosidase gene; Blood; Gaucher disease; GBA g.S84GG; GBA1; GBA1 (LL); GC (SP); GCB; Genetics; GLUC; GLUC (LL); Glucocerebrosidase gene; glucosidase, beta, acid; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.4	2.13	AssociatedObservations	EXTERNAL_COPYRIGHT_LINK	HL7_ATTACHMENT_STRUCTURE	CONSUMER_NAME	EXAMPLE_UCUM_UNITS	STATUS_REASON	STATUS_TEXT	CHANGE_REASON_PUBLIC	COMMON_TEST_RANK	COMMON_ORDER_RANK
35371-4	GBA gene.g.N370S	Arb	Bld/Tiss	Pt	Ord	Molgen	DEPRECATED	Deprecated GBA gene.g.N370S [Presence] in Blood or Tissue by Molecular genetics method	DEL	DefinitionDescription			MOLPATH.MUT	35371-4	Molgen	Both	Deprecated GBA g.N370S Bld/T Ql	N	Arbitrary; Beta glucosidase gene; Blood; Gaucher disease; GBA g.N370S; GBA1; GBA1 (LL); GC (SP); GCB; Genetics; GLUC; GLUC (LL); Glucocerebrosidase gene; glucosidase, beta, acid; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.4	2.13	AssociatedObservations	EXTERNAL_COPYRIGHT_LINK	HL7_ATTACHMENT_STRUCTURE	CONSUMER_NAME	EXAMPLE_UCUM_UNITS	STATUS_REASON	STATUS_TEXT	CHANGE_REASON_PUBLIC	COMMON_TEST_RANK	COMMON_ORDER_RANK
35372-2	GBA gene.p.Leu444Pro	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	GBA gene p.Leu444Pro [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.MUT	35372-2	Molgen	Both	GBA p.L444P Bld/T Ql	N	Beta glucosidase gene; Blood; Gaucher disease; GBA p.L444P; GBA1; GBA1 (LL); GC (SP); GCB; Genetics; GLUC; GLUC (LL); Glucocerebrosidase gene; glucosidase, beta, acid; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.56	2.13								Changed Component name to align with the current HGVS recommendations to use the three letter codes for amnio acids. In the shortname, we kept the single letter codes.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35373-0	Platelet aggregation.XXX induced	RelACnc	PRP^Donor	Pt	Qn		ACTIVE	Platelet aggregation XXX induced in Platelet rich plasma from Donor	MAJ	DefinitionDescription			COAG	35373-0		Observation	PA XXX PRP Donr	N	Agg; Aggr; COAGULATION; Donr; Hematology; Heme; PA; PA XXX; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	2.54	2.13								Property changed from ThrSCnc to better fit the procedure employed.	0
35374-8	DMPK gene allele 2.CTG repeats	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	DMPK gene allele 2 CTG repeats [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.NUCREPEAT	35374-8	Molgen	Observation	DMPK allele2 CTG Rpt Bld/T Ql	N	Blood; DM; DM1; DM1PK; DMK; DMPK allele2; DMPK allele2 CTG Rpt; dystrophia myotonica-protein kinase; Dystrophia myotonica-protein kinase gene; Genetics; Heredity; Heritable; II; Inherited; MDPK; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.NUCREPEAT; MT-PK; Myotonic dystrophy 1; Myotonin-protein kinase gene; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Repeat; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.64	2.13								The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35375-5	DMPK gene allele 1.CTG repeats	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	DMPK gene allele 1 CTG repeats [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.NUCREPEAT	35375-5	Molgen	Observation	DMPK allele1 CTG Rpt Bld/T Ql	N	Blood; DM; DM1; DM1PK; DMK; DMPK allele1; DMPK allele1 CTG Rpt; dystrophia myotonica-protein kinase; Dystrophia myotonica-protein kinase gene; Genetics; Heredity; Heritable; i; Inherited; MDPK; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.NUCREPEAT; MT-PK; Myotonic dystrophy 1; Myotonin-protein kinase gene; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Repeat; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.64	2.13								The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35376-3	MJD gene allele 2.CAG repeats	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	MJD gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.NUCREPEAT	35376-3	Molgen	Observation	MJD allele2 CAG Rpt Bld/T Ql	N	AT3; Ataxia-3; Ataxin 3; ATX3; Blood; Genetics; Heredity; Heritable; II; Inherited; JOS; Machado-Joseph disease; MJD; MJD allele2 CAG Rpt; MJD1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.NUCREPEAT; Olivopontocerebellar ataxia 3; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Repeat; SCA3; SCA3 gene; Screen; Spinocerebellar ataxia; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.56	2.13								Changed Property from Arb (Arbitrary) to 'Threshold' since the results (e.g. positive, intermediate, negative) is based on the number of nucleotide repeats. Moved term from Class MOLPATH.TRINUC to MOLPATH.NUCREPEAT, a Class used to group together observations for nucleotide repeats.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35377-1	MJD gene allele 1.CAG repeats	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	MJD gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.NUCREPEAT	35377-1	Molgen	Observation	MJD allele1 CAG Rpt Bld/T Ql	N	AT3; Ataxia-3; Ataxin 3; ATX3; Blood; Genetics; Heredity; Heritable; i; Inherited; JOS; Machado-Joseph disease; MJD; MJD allele1 CAG Rpt; MJD1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.NUCREPEAT; Olivopontocerebellar ataxia 3; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Repeat; SCA3; SCA3 gene; Screen; Spinocerebellar ataxia; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.56	2.13								Changed Property from Arb (Arbitrary) to 'Threshold' since the results (e.g. positive, intermediate, negative) is based on the number of nucleotide repeats. Moved term from Class MOLPATH.TRINUC to MOLPATH.NUCREPEAT, a Class used to group together observations for nucleotide repeats.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35378-9	HNPCC genes mutations tested for	Prid	Bld/Tiss	Pt	Nom	Molgen	ACTIVE	HNPCC genes mutations tested for in Blood or Tissue by Molecular genetics method Nominal	NAM	DefinitionDescription		RESULT COMMENT: IMMUNOHISTOCHEMICAL STAINING (IHC) IS USED TO DETERMINE THE PRESENCE OR ABSENCE OF PROTEIN EXPRESSION FOR HMLH1, HMSH2, AND HMSH6. LYMPHOCYTES AND Normal EPITHELIUM EXHIBIT STRONG NUCLEAR STAINING AND SERVE AS Positive INTERNAL CONTROLS FOR STAINING OF THESE PROTIENS. A PCR BASED ASSAY IS USED TO TEST FOR TUMOR MICROSATELLITE INSTABILITY (MSI) WITH THE USE OF 10 MARKERS: 4 MONONUCLEOTIDE REPEATS (BAT25, BAT26, BAT40, BAT34C) AND 6 DINUCLEOTIDE REPEATS (D17S250, D5S346, D18S55, D10S197, MYCL, AND ACTC).	MOLPATH.MUT	35378-9	Molgen	Observation	HNPCC genes Mut Tested Bld/T	N	Blood; COCA2; FCC2; Genetics; Hereditary Nonpolyposis Colorectal Cancer; Heredity; Heritable; hMLH1; HNPCC; HNPCC2; Identity or presence; Inherited; Lynch syndrome; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; mutL homolog 1; Muts; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.54	2.13								Changed "gene" to "genes" in Component since multiple genes to clarify that "HNPCC" is the disease acrynoym and not an approved HGNC gene name. This change also clarifies that mutations in multiple genes are being analyzed.	0
35379-7	HNPCC genes targeted mutation analysis	Prid	Bld/Tiss	Pt	Nom	Molgen	ACTIVE	HNPCC genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	MIN	DefinitionDescription		RESULT COMMENT: THE RECTOSIGMOID COLON ADNOCARCINOMA DEMONSTRATED THE PRESENCE OF Normal HMLH1, HMSH2, AND HMSH6 PROTIEN EXPRESSION AND MSI TESTING DEMONSTRATED A STABLE PATTER IN 8 OF 8 INFORMATIVE MARKERS (MSS).	MOLPATH.MUT	35379-7	Molgen	Both	HNPCC genes Mut Anl Bld/T	N	Blood; COCA2; FCC2; Genetics; Hereditary Nonpolyposis Colorectal Cancer; Heredity; Heritable; hMLH1; HNPCC; HNPCC2; Identity or presence; Inherited; Lynch syndrome; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; mutL homolog 1; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.73	2.13								Changed "gene" to "genes" in Component since multiple genes to clarify that "HNPCC" is the disease acrynoym and not an approved HGNC gene name. This change also clarifies that multiple genes are being analyzed. Based on LOINC Committee review (June 2016), "targeted" was added to the Component to clarify that this test is looking for a specific set of mutations as described in the LOINC User Guide under the Molecular Genetics section.	0
3538-6	Dextromethorphan	PrThr	Ser/Plas	Pt	Ord		ACTIVE	Dextromethorphan [Presence] in Serum or Plasma	MIN	DefinitionDescription			DRUG/TOX	3538-6		Both	D-methorphan SerPl Ql		Dextro-methorphan; D-methorphan; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	2.56	1								The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35380-5	HEXA gene.c.IVS7+1G>A	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	HEXA gene c.IVS7+1G>A [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.MUT	35380-5	Molgen	Both	HEXA c.IVS7+1G>A Bld/T Ql	N	beta-N-acetylhexosaminidase gene; Blood; Genetics; GIVS7C; GM2-gangliosidosis; Heredity; Heritable; HEXA c.IVS7+1G>A; hexosaminidase A (alpha polypeptide); hexosaminidase A (alpha polypeptide) gene; Inherited; inversion 7; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; N-acetyl-beta-glucosaminidase gene; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tay-Sachs disease; Tissue; Tissue, unspecified; TSD; WB; Whole blood; Whole blood or Tissue	2.56	2.13								Added method; Changed Component part from g.GIVS7A to c.IVS7+1G>A since variant is described at coding level and to harmonize with HGVS nomenclature guidelines.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35381-3	HEXA gene.c.IVS12+1G>C	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	HEXA gene c.IVS12+1G>C [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.MUT	35381-3	Molgen	Both	HEXA .c.IVS12+1G>C Bld/T Ql	N	beta-N-acetylhexosaminidase gene; Blood; Genetics; GIVS12C; GM2-gangliosidosis; Heredity; Heritable; HEXA .c.IVS12+1G>C; hexosaminidase A (alpha polypeptide); hexosaminidase A (alpha polypeptide) gene; Inherited; inversion 12; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; N-acetyl-beta-glucosaminidase gene; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tay-Sachs disease; Tissue; Tissue, unspecified; TSD; WB; Whole blood; Whole blood or Tissue	2.56	2.13								Changed Component part from g.GIVS12C to c.IVS12+1G>C since variant is described at coding level and to harmonize with HGVS nomenclature guidelines.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35382-1	HEXA gene.p.Gly269Ser	PrThr	Bld/Tiss	Pt	Ord	Molgen	ACTIVE	HEXA gene p.Gly269Ser [Presence] in Blood or Tissue by Molecular genetics method	MIN	DefinitionDescription			MOLPATH.MUT	35382-1	Molgen	Both	HEXA p.G269S Bld/T Ql	N	beta-N-acetylhexosaminidase gene; Blood; Genetics; Gly269Ser; GM2-gangliosidosis; Heredity; Heritable; HEXA p.G269S; hexosaminidase A (alpha polypeptide); hexosaminidase A (alpha polypeptide) gene; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; N-acetyl-beta-glucosaminidase gene; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs121907954; Screen; Tay-Sachs disease; Tissue; Tissue, unspecified; TSD; WB; Whole blood; Whole blood or Tissue	2.56	2.13								Changed Component part from g.G269S to p.G269S since variant is at described at protein level vs. genomic level. Changed Component name to align with the current HGVS recommendations to use the three letter codes for amnio acids. In the shortname, we kept the single letter codes.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
35383-9	Galactomannan Ag	ACnc	Ser/Plas	Pt	Qn		ACTIVE	Galactomannan Ag [Units/volume] in Serum or Plasma	MIN	DefinitionDescription	Index	Indes = 0.16	MICRO	35383-9		Both	Galactomannan Ag SerPl-aCnc	N	Antigen; Antigens; Arbitrary concentration; Aspergillus galactomannan; GM; ID; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders	2.73	2.13					{Index_val}				0
35384-7	Estradiol	MCnc	Ser/Plas	Pt	Qn	High sensitivity	ACTIVE	Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method	MIN	DefinitionDescription	pg/mL		CHEM	35384-7	High sensitivity	Both	Estradiol SerPl HS-mCnc	N	17-beta estradiol; Chemistry; E2; Gyn; Gynecology; HS; Level; Mass concentration; OB; ObGyn; Obstetrics; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders	2.73	2.13					pg/mL				0